Randomized, Double Blind, a Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of CJ-50300 in Healthy Volunteers
Phase of Trial: Phase II/III
Latest Information Update: 18 Jun 2014
At a glance
- Drugs CJ 50300 (Primary)
- Indications Smallpox
- Focus Adverse reactions; Pharmacodynamics
- 26 Aug 2010 Status changed from recruiting to completed.
- 29 Jun 2010 Results reported in Vaccine.
- 04 Mar 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History